Drug Patents owned by Janssen Prods

1. Drug name - EDURANT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8080551 JANSSEN PRODS HIV inhibiting pyrimidines derivatives
Apr, 2023

(6 months from now)

US7125879 JANSSEN PRODS HIV inhibiting pyrimidines derivatives
Apr, 2025

(2 years from now)

CN101056673A JANSSEN PRODS 4-[[4-[[4-(2-Cyanovinyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidyl]Amino] Benzonitrile Hydrochloride
Jun, 2015

(7 years ago)

CN101816658A JANSSEN PRODS Pyramine Derivatives For Inhibiting Hiv
Aug, 2022

(a month ago)

CN101816658B JANSSEN PRODS Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN1541215A JANSSEN PRODS Hiv Inhibiting Pyrimidine Derivatives
Aug, 2022

(a month ago)

CN100509801C JANSSEN PRODS Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN101060844A JANSSEN PRODS Composition Of Rt Inhibitor And Nnrti Containing Pyrimidine
Sep, 2024

(1 year, 10 months from now)

CN101068597A JANSSEN PRODS Fumaric Acid Salt Of 4-((4-((4-(2-Cyanovinyl)-2, 6-) Dimethylphenyl Amido)-2- Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 10 months from now)

CN101068597B JANSSEN PRODS 4 - ((4 - ((4 - (2) -2, 6 -) Dimethylphenyl Amido) -2 - Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 10 months from now)

CN101060844B JANSSEN PRODS Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Sep, 2024

(1 year, 10 months from now)

IN200400265P1 JANSSEN PRODS Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

IN222987B JANSSEN PRODS A Pyrimidine Compound Of Formula (I)
Aug, 2022

(a month ago)

EP1663240A1 JANSSEN PRODS Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP1663240B1 JANSSEN PRODS Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP1632232A1 JANSSEN PRODS Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP1632232B1 JANSSEN PRODS Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP3808743B1 JANSSEN PRODS Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761B1 JANSSEN PRODS Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP3808743A1 JANSSEN PRODS Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761A1 JANSSEN PRODS Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP1789139A1 JANSSEN PRODS Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1789139B1 JANSSEN PRODS Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1419152B1 JANSSEN PRODS Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

EP1419152A1 JANSSEN PRODS Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7638522 JANSSEN PRODS Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile Apr, 2023

(6 months from now)

More Information on Dosage
Strength Dosage Availability
EQ 25MG BASE TABLET;ORAL Prescription

2. Drug name - OLYSIO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7671032 JANSSEN PRODS HCV NS-3 serine protease inhibitors
May, 2025

(2 years from now)

US8349869 JANSSEN PRODS Macrocylic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US9856265 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US9040562 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US8741926 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US8754106 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US8148399 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Sep, 2029

(6 years from now)

CN1914224B JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitor
Jan, 2020

(2 years ago)

CN1914224A JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
Jan, 2020

(2 years ago)

CN102627639B JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2020

(2 years ago)

CN102627639A JANSSEN PRODS Macrocyclic Inhibitor Of Hepatitis C Virus
Jul, 2020

(2 years ago)

CN103030636B JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2020

(2 years ago)

CN103030636A JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2020

(2 years ago)

CN101228169B JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2020

(2 years ago)

CN101228169A JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2020

(2 years ago)

CN1914225A JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
Jan, 2021

(1 year, 8 months ago)

CN1914225B JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
Jan, 2021

(1 year, 8 months ago)

IN200603860P1 JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
Jan, 2025

(2 years from now)

IN256631B JANSSEN PRODS Cyclopentanyl Containing Macrocyclic Hcv Ns-3 Protease Inhibitors
Jan, 2025

(2 years from now)

IN294307B JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2026

(3 years from now)

IN200710158P1 JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2026

(3 years from now)

EP1713822B1 JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
Jan, 2025

(2 years from now)

EP1713822A2 JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
Jan, 2025

(2 years from now)

EP2322516A1 JANSSEN PRODS Intermediates For The Preparation Of Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2026

(3 years from now)

EP2322516B1 JANSSEN PRODS Intermediates For The Preparation Of Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2026

(3 years from now)

EP1912999A1 JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2026

(3 years from now)

EP1912999B1 JANSSEN PRODS Macrocyclic Inhibitors Of Hepatitis C Virus
Jul, 2026

(3 years from now)

EP1713823B1 JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
May, 2029

(6 years from now)

EP1713823A2 JANSSEN PRODS Hcv Ns-3 Serine Protease Inhibitors
May, 2029

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9623022 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus Jul, 2026

(3 years from now)

US9353103 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus Jul, 2026

(3 years from now)

Drugs and Companies using SIMEPREVIR SODIUM ingredient

Treatment: Method of treating hepatitis c

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 150MG BASE CAPSULE;ORAL Discontinued

3. Drug name - PREZCOBIX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8518987 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Feb, 2024

(1 year, 4 months from now)

US7700645 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Dec, 2026

(4 years from now)

US8148374 JANSSEN PRODS Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

CN101796040A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN100402539C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1443189A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100475819C JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN1668623A JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN101679325A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B JANSSEN PRODS Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101679325B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN208435B JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN241597B JANSSEN PRODS Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200810487P1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN332719B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2682397B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1567529A2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2487165A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2118082B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2170851B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810B1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810A1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8518987

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Aug, 2024

(1 year, 10 months from now)

US7700645

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Jun, 2027

(4 years from now)

US10039718 JANSSEN PRODS Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

More Information on Dosage
Strength Dosage Availability
150MG;800MG TABLET;ORAL Prescription

4. Drug name - PREZISTA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8518987 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Feb, 2024

(1 year, 4 months from now)

US7700645 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Dec, 2026

(4 years from now)

CN101796040A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN100402539C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1443189A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100475819C JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN1668623A JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN101679325A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B JANSSEN PRODS Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101679325B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN208435B JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN241597B JANSSEN PRODS Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200810487P1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN332719B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2682397B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1567529A2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2487165A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2118082B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2170851B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810B1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810A1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8518987

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Aug, 2024

(1 year, 10 months from now)

US7700645

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Jun, 2027

(4 years from now)

Drugs and Companies using DARUNAVIR ingredient

Treatment: NA

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
100MG/ML SUSPENSION;ORAL Prescription

5. Drug name - SYMTUZA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8518987 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Feb, 2024

(1 year, 4 months from now)

US7390791 JANSSEN PRODS Prodrugs of phosphonate nucleotide analogues
Apr, 2025

(2 years from now)

US7700645 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Dec, 2026

(4 years from now)

US8148374 JANSSEN PRODS Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

US9296769 JANSSEN PRODS Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

US8754065 JANSSEN PRODS Tenofovir alafenamide hemifumarate
Aug, 2032

(9 years from now)

CN101796040A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN100402539C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1443189A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1706855A JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN1291994C JANSSEN PRODS Phosphonate Nucleotide Analog Prodrug And Screening And Preparing Method Thereof
Jul, 2021

(1 year, 2 months ago)

CN100475819C JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN1668623A JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN101679325A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B JANSSEN PRODS Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101679325B JANSSEN PRODS Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN208435B JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200600529P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues
Jul, 2021

(1 year, 2 months ago)

IN241597B JANSSEN PRODS Methoxy Phosphonate Nucleotide Prodrug
Jul, 2021

(1 year, 2 months ago)

IN200300009P3 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

IN200810487P1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN332719B JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2682397B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP2682397A1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519A2 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1301519B1 JANSSEN PRODS Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Jul, 2021

(1 year, 2 months ago)

EP1567529A2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2487165A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2118082B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2170851B1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 JANSSEN PRODS Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2744810B1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

EP2744810A1 JANSSEN PRODS Tenofovir Alafenamide Hemifumarate
Aug, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10039718 JANSSEN PRODS Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

US10786518 JANSSEN PRODS Compositions and methods of treating HIV Jul, 2038

(15 years from now)

Drugs and Companies using COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE ingredient

Treatment: Treatment of hiv-1 infection in adult or pediatric patients (>=40 kg) with <50 copies/ml hiv-1 rna after >= 6 months on prior antiretroviral regimen and no known darunavir or tenofovir resistance-associated substitutions

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
150MG;800MG;200MG;EQ 10MG BASE TABLET;ORAL Prescription

6. Drug name - YONDELIS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8895557 JANSSEN PRODS Pharmaceutical formulations of ecteinascidin compounds Jan, 2028

(5 years from now)

US8895557

(Pediatric)

JANSSEN PRODS Pharmaceutical formulations of ecteinascidin compounds Jul, 2028

(5 years from now)

Drugs and Companies using TRABECTEDIN ingredient

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
1MG/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.